Get the Stockscreener App
12.75
0.55%
-0.07
Pre-market:
13.99
1.24
+9.73%
Gyre Therapeutics Inc Stock (GYRE) Latest News
Gyre therapeutics president Ma Songjiang sells $48,029 in stock - Investing.com
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Up 14.4% in January - MarketBeat
Insider Selling: Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Sells 2,000 Shares of Stock - MarketBeat
Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Sells $22,360.00 in Stock - MarketBeat
Gyre Therapeutics president sells $45,380 in stock - MSN
Gyre Therapeutics president sells $45,380 in stock By Investing.com - Investing.com Australia
Gyre Therapeutics president Ma Songjiang sells $42,760 in stock - MSN
Gyre Therapeutics president Ma Songjiang sells $42,760 in stock By Investing.com - Investing.com Australia
Gyre Therapeutics, Inc. (NASDAQ:GYRE) President Songjiang Ma Sells 2,000 Shares - MarketBeat
Songjiang Ma Sells 2,000 Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE) Stock - MarketBeat
Gyre Therapeutics president Ma Songjiang sells shares worth $42,960 By Investing.com - Investing.com Nigeria
Gyre Therapeutics president Ma Songjiang sells shares worth $42,960 - MSN
Barclays PLC Has $116,000 Stock Holdings in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World
Gyre Therapeutics president Ma Songjiang sells shares for $42,860 - MSN
Gyre Therapeutics president Ma Songjiang sells shares for $42,860 By Investing.com - Investing.com Australia
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Up 14.4% in December - MarketBeat
Gyre Therapeutics president Ma Songjiang sells $42,480 in stock - MSN
Gyre Therapeutics president Ma Songjiang sells $42,480 in stock By Investing.com - Investing.com South Africa
Gyre Therapeutics president Songjiang Ma sells $11,156 in stock By Investing.com - Investing.com South Africa
Songjiang Ma Sells 1,057 Shares of Gyre Therapeutics, Inc. (NASDAQ:GYRE) Stock - MarketBeat
Gyre Therapeutics president Songjiang Ma sells $11,156 in stock - Investing.com
Barclays PLC Has $116,000 Stock Position in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World
Gyre Therapeutics president Ma Songjiang sells $22,336 in stock - Investing.com
Geode Capital Management LLC Has $3.81 Million Stock Position in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World
Leadership Changes at Gyre Therapeutics Amid Strategic Shift - TipRanks
Gyre Therapeutics (NASDAQ:GYRE) Shares Down 3.2%Time to Sell? - MarketBeat
Gyre Therapeutics Reshapes Leadership: Appoints String Capital's Ping Zhang as Lead Director - StockTitan
Gyre Therapeutics president Ma Songjiang sells $49,600 in stock By Investing.com - Investing.com Australia
State Street Corp Grows Position in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):